- PERFECT (inhaled treprostinil)
-
Product
PERFECT
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase 3Phase 3 clinical trial with Tyvaso® (treprostinil) Inhalation Solution for the treatment of pulmonary hypertension due to chronic obstructive pulmonary disease (PH-COPD).
LEARN MORE Close - TETON Studies (inhaled treprostinil)
-
Therapeutic Platform
Tyvaso®Targeted Indication
Idiopathic Pulmonary Fibrosis (IPF)Status
Phase 3Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies of the Efficacy and Safety of Inhaled Treprostinil in Patients with Idiopathic Pulmonary Fibrosis (IPF).
LEARN MORE Close
Menu